Gupta V, Kennedy JA, Capo-Chichi J-M, et al. Genetic factors rather than blast reduction determine outcomes of allogeneic HCT in BCR-ABL–negative MPN in blast phase. Blood Adv. 2020;4(21):5562-5573.

doi:10.1182/bloodadvances.2021005068

In “Acknowledgments” on page 5571, NIH/National Heart, Lung, and Blood Institute grant OT3HL147741 should not have been cited. The error has been corrected in the published article.

2021

Gupta V, Kennedy JA, Capo-Chichi J-M, et al. Genetic factors rather than blast reduction determine outcomes of allogeneic HCT in BCR-ABL–negative MPN in blast phase. Blood Adv. 2020;4(21):5562-5573.

Cited By

Email alerts

ASH Publications

American Society of Hematology

Gupta V, Kennedy JA, Capo-Chichi J-M, et al. Genetic factors rather than blast reduction determine outcomes of allogeneic HCT in BCR-ABL–negative MPN in blast phase. Blood Adv. 2020;4(21):5562-5573.

Cited By

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only